Su-Wei Kuo

Su-Wei Kuo is a Senior Advisor at Eli Lilly and Company, where they are currently engaged in research. They completed their Ph.D. in Neuroscience at Northwestern University, during which they studied motor neuron excitability related to Amyotrophic Lateral Sclerosis. Prior to that, Kuo served as a postdoctoral associate at Duke University, focusing on the mechanisms of spinal cord stimulation for chronic pain management. They also hold a Master of Science in Molecular Medicine from The University of Sheffield and a Bachelor of Science in Biotechnology/Agricultural Chemistry from National Taiwan University.